VA expands spinal cord injury care, opens door to assistive tech makers
H.R. 6835 — Veterans STAND Act · Filed by Jack Bergman (R-MI) · 21 cosponsors · Introduced Dec 18, 2025 · Hearing held
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the VA to offer annual preventative health evaluations to veterans with spinal cord injuries or disorders, covering risk assessment, chronic pain management, dietary/weight management, prosthetic equipment review, and assistive technologies (including spinal cord stimulation devices). The VA must consult with specialists and manufacturers when developing guidance, report annually to Congress on usage and outcomes, and may provide training and remote monitoring for these technologies via telehealth.
Why we flagged it
The bill's operative mechanism is a mandate to expand VA service delivery (preventative evaluations and assistive technology access) to a defined veteran population. It is not a tax measure, appropriation, or deregulation—it is a service-delivery expansion.
What the text implies
- Manufacturers of assistive technologies and spinal cord neuromodulation devices (including implantable systems) gain a structured pathway to VA procurement and clinical adoption through mandatory consultation and reporting requirements, potentially creating a market-development channel within federal healthcare.
- The bill's requirement that the VA consult with 'manufacturers of assistive technologies' before issuing guidance may create informal lobbying access and influence over VA clinical standards, though the text does not grant veto power.
- Telehealth provision for training, programming, and remote monitoring of assistive technologies may shift care delivery away from in-person VA clinics toward remote models, with unclear implications for rural veterans or those with limited digital access.
- The biennial reporting requirement on assistive technology usage and outcomes creates a federal data stream on device performance and veteran outcomes, which may be used by manufacturers for marketing or regulatory submissions to FDA.
- The bill does not specify funding mechanisms or appropriations, leaving implementation dependent on VA budget allocation and potentially creating competition with other VA priorities.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Veterans with spinal cord injuries gain structured access to preventative care, assistive technologies, and specialized evaluations they may not otherwise receive, with no apparent cost-shifting to beneficiaries. The bill expands VA service obligations without restricting veteran eligibility or creating new barriers.
Who stands to gain
- Assistive technology manufacturers (mobility devices, speech-generating devices, spinal cord stimula
- Spinal cord neuromodulation device companies (transcutaneous and implantable systems)
- Telehealth service providers contracted by VA
- Medical device suppliers and prosthetics manufacturers
Named in the bill
Department of Veterans Affairs (VA), Secretary of Veterans Affairs, Veterans Integrated Service Networks (VISN), House Committee on Veterans' Affairs, Senate Committee on Veterans' Affairs, Food and Drug Administration (FDA), Assistive technology manufacturers, Spinal cord injury and disorder specialists
Where it stands
21 cosponsors: 11 Democrats, 10 Republicans.
- Dec 18, 2025 — Introduced · Congress.gov: “Introduced in House”
- Dec 18, 2025 — Referred to House Committee on Veterans' Affairs · Congress.gov: “Referred to the House Committee on Veterans' Affairs”
- Jun 30, 2026 — Hearing held · Congress.gov: “Subcommittee Hearings Held”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
4 lobbying clients named this bill on 4 disclosure filings across 2 quarters, Mar 2026 to Jun 2026. Those filings disclosed $727,000 in lobbying spend. A filing names 10 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 72% of bills with at least one filing.
Jack Bergman, the sponsor, reported $844,675 in PAC receipts in the 2026 cycle. $2,500 of that came from 1 PAC tied to these lobbying clients.
- Boston Scientific Corporation — $642,000 on 1 filing
- Cure Sma — $75,000 on 1 filing
- Onward Medical, Inc. — $10,000 on 1 filing
- United Spinal Association — $0 on 1 filing
Lobbying Disclosure Act filings through Jul 17, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (5,416 characters) on Aug 20, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Mar 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 17, 2026 · page rendered 2026-10-20.
“VA expands spinal cord injury care, opens door to assistive tech makers” QuorumCivic. https://share.quorumcivic.app/bill/119/hr6835 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.